SCHEMBL10277045

SCHEMBL10277045

c1ccc(-c2ccc(-c3cccc(-n4c5ccccc5c5cc(N(c6ccc(-c7ccccc7)cc6)c6ccc(-c7ccccc7)cc6)ccc54)c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TSPO P30536 4/20 0.41
ALDH1A1 P00352 2/20 0.36
HTT P42858 2/20 0.36
FAAH O00519 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PKM P14618 1/20 0.36
MGLL Q99685 1/20 0.36
KMT2A Q03164 2/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
IL1R1 P14778 1/20 0.34
HDAC4 P56524 1/20 0.34
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
PTGER4 P35408 1/20 0.33
PDE10A Q9Y233 1/20 0.33
RAC2 P15153 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252092 1.00 ATM (0.46) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL10315676 0.99 ATM (0.45) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL10315692 0.99 ATM (0.45) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL14119376 0.99 ATM (0.45) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL10315675 0.99 ATM (0.45) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL17598783 0.96 ATM (0.47) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL24722202 0.95 ATM (0.41) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL17722294 0.95 ATM (0.44) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL6374077 0.95 ATM (0.44) ATML3MBTL1KDM4ETSPOALDH1A1
SCHEMBL13803711 0.95 ATM (0.44) ATML3MBTL1KDM4ETSPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450192-B2 Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof E-RAY OPTOELECTRONICS TECHNOLOGY (TW) 2016-09-20 US disclosed
US-9450192-B2 Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof E-RAY OPTOELECTRONICS TECHNOLOGY (TW) 2016-09-20 US disclosed
US-9450192-B2 Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof E-RAY OPTOELECTRONICS TECHNOLOGY (TW) 2016-09-20 US disclosed
US-20120175598-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2012-07-12 US disclosed
US-20120175598-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2012-07-12 US disclosed
US-20120175598-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120175598-A1 CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF AHR, ARNT, NAT1 ATM 2102/4885L3MBTL1 2732/4885KDM4E 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.